GlassScriptPhysician profile
Zack A Nash
NPI 1962722371
$2,050.13
in general payments reported to CMS, 2019-2025
13 companies · $552 in 2025
The $552 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $83.55 · 2021: $45.66 · 2022: $18.27 · 2023: $72.41 · 2024: $51.99 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $400.51 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $234.57 | 2019 | |
| Cook Medical LLC | $205.97 | 2025 | Rosen, Cook |
| Endologix LLC | $205.54 | 2025 | Afx2 Bifurcated Endograft System |
| Amarin Pharma, INC. | $203.19 | 2019 | |
| Amgen INC. | $152.98 | 2019-2020 | |
| Silk Road Medical, INC. | $136.50 | 2019 | |
| Medtronic, INC. | $131.13 | 2023-2025 | Endurant Iis, In.Pact Admiral |
| Pfizer INC. | $119.03 | 2019 | |
| W. L. Gore & Associates, INC. | $116.67 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Lemaitre Vascular, INC. | $67.28 | 2019-2023 | Artegraft Vascular Graft |
| Abbott Laboratories | $44.21 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $32.55 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zack Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.